Atherosclerotic Cardiovascular Disease (ASCVD)
An Interactive Learning Experience Sponsored by Novartis Pharmaceuticals Corporation; Not for CME/CE CreditThis course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death globally. An effort to reduce the mortality risk to patients must include prevention and optimal treatment of patients with the greatest individual and combined risk factors including hypertension and hyperlipidemia, as well as other comorbid conditions that contribute to cardiovascular health. This module is intended to:
This content is developed exclusively by or on behalf of the industry sponsor through a third party and is not reviewed by Pri-Med. The content and opinions expressed are those of the sponsor or presenters and may not reflect the views of Pri-Med.
1/22 164993
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.